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Abstract
Background: Matrix Metalloproteinase functions in the remodeling of the extracellular matrix
that is integral for many normal and pathological processes such as morphogenesis, angiogenesis,
tissue repair, and tumor invasion. The tissue inhibitor of the metalloproteinase family including the
tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates the activity of multifunctional
metalloproteinase. It is known that IL-8, the target gene of NF-κB pathway, increases in the
melanoma cells. However, it is not clear whether the TIMP-2 expression regulates the NF-κB
pathway. In this study, we have used stable melanoma cell lines, parental A2058, A2058T2-1
overexpressing TIMP-2, and A2058T2R-7 underexpressing TIMP-2, to determine the TIMP-2
regulation of the NF-κB activity.
Results: We found that the IL-8 secretion and IL-8 mRNA expression significantly increased in the
A2058T2-1 overexpressing TIMP-2. TIMP-2 overexpressed cells had the lower basal level of IκBα,
the inhibitor of NF-κB, compared to the parental A2058 cells. The transcriptional NF-κB activity
was increased by the TIMP-2 overexpression. In contrast, A2058T2R-7 underexpressing TIMP-2
had the similar NF-κB activity as that in the parental A2058 cell. The apoptotic cells induced by
TNF were less in TIMP-2 over-expression cells compared to those in the parental A2058 cells.
TIMP-2 over-expression was able to protect cells from apoptosis.
Conclusion: Our data demonstrate that the expression level of TIMP-2 protein can directly
modulate the NF-κB pathway in human melanoma cells.
Background
The tissue inhibitor of the metalloproteinases family
including the tissue inhibitor of metalloproteinases-2
(TIMP-2) regulates the activity of multifunctional metal-
loproteinases, which regulate the pathogenesis of
melanoma and other diseases [1,2]. Nuclear factor-κB
(NF-κB) is a family of transcription factors that play an
essential role in innate and adaptive immune responses,
cell proliferation, apoptosis, and tumorigenesis [3-6].
Constitutive activation of nuclear factor-B (NF-B) has
been directly implicated in tumorigenesis of various can-
cer types, including melanoma [3-5]. NF-κB is active in
the nucleus and its activity is inhibited by the inhibitor of
κBα (IκBα). IκBα binds to NF-κB to block the nuclear
localization signal so that the NF-κB dimer (p50 & p65) is
retained in the cytoplasm. Phosphorylation of IκBα by
IκB kinase (IKK) initiates the ubiquitination and degrada-
tion of IκB, leading to nuclear translocation and activa-
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tion of NF-κB [6]. It is known that IL-8, the target gene of
NF-κB, increases in the melanoma cells [7,8]. However,
the upstream signalling pathways leading to NF-κB activ-
ity in malignant melanoma are unknown until today. It is
not clear whether TIMP-2 expression directly regulates the
proinflammatory NF-κB pathway.
We have established stable melanoma cell lines: parental
A2058 expressing, A2058T2-1 overexpressing, and
A2058T2R-7 underexpressing TIMP-2 [9]. Alternation of
the TIMP-2-production is correlated with changes in the
morphology of the infectant cell lines. A2058T2R-7 cells
underexpressing TIMP-2 are smaller, more elongated, and
spindle shaped in appearance compared to the parental
A2058. A2058T2-1 overexpressing TIMP-2 cells have
more sites for peripherial cell attachment and are larger,
more spread than the A2058 parental cells. In addition,
TIMP-2 expression has an effect on the cell attachment.
Cell line with overexpression TIMP-2 showed increased
adhesion to tissue culture plastics, gelatine, fibronectin,
and vitronectin [9]. In the current study, we used these cell
lines to examine the relationship between TIMP-2 expres-
sion and NF-κB activity in melanoma cells. The TIMP-2
regulation of the NF-κB activity was investigated at differ-
ent levels including total and phosphorylated IκBα, p65
phosphorylation, NF-κB transcriptional activity, target
gene IL-8 expression, and cell apoptosis.
Results
TIMP-2 expression increases the IL-8 protein secretion and 
IL-8 mRNA expression
Many pro-inflammatory cytokines and chemokines, such
as IL-8, IL-6, and TNF-α, are targets of NF-κB regula-
tion[10,11]. Because IL-8 secretion increased in the
melanoma cells, we first assessed the effect of TIMP-2
expression on the IL-8 secretion in cells cultured in
DMEM for 24 hours and reached 70% confluence. As
shown here (Fig. 1A), there is a significant difference of IL-
8 secretion in the cell lines with different level of TIMP-2
expression. TIMP-2 over-expression in A2058T2-1 cells
significantly increased the IL-8 protein secreted in the cell
media. In addition, IL-8 real-time PCR showed that the IL-
8 mRNA was increased with TIMP-2 over-expression in
A2058T2-1 cells without any stimulation (Fig. 1B).
TIMP-2 over-expression decreases IκBα, inhibitor of NF-
κB activity
One assay commonly used to demonstrate the activation
of the pro-inflammatory NF-κB signalling pathway is the
degradation of the NF-κB inhibitory molecule IκBα (Fig.
2A). We found that the basal level of IκBα in the TIMP-2
over-expressed cells was lower than that in the parental
A2058 cells. IκBα degradation involves phosphorylation,
ubiquitination, and subsequent proteasomal degrada-
tion. Without any stimulation, the alteration of the phos-
phorylated IκBα (phosphor- IκBα) could be detected in
these three cell lines. Phosphor- IκBα was increased in the
TIMP-2 over-expressed cells (Fig. 2B), which is consistent
with the reduced level of total IκBα.
TIMP-2 over-expression elevates the phosphorylation of 
NF-κB p65
It should be noted that NF-κB activity is regulated by
phosphorylation. Transcriptional activity of NF-κB is con-
trolled by phosphorylation of p65 at serine 536 [12,13].
The increased level of phosphorylated NF-κB P65 (p-P65)
indicates the high activity of NF-κB pathway. We further
determined the total p65 and p-p65 expression by West-
ern blot (Fig. 3A). There was only a sight difference of the
IL-8 protein and mRNA expression in cell lines A2058,  A2058T2-1, and A2058T2R-7 Figure 1
IL-8 protein and mRNA expression in cell lines 
A2058, A2058T2-1, and A2058T2R-7. (A) IL-8 secretion 
in cell lines A2058, A2058T2-1, and A2058T2R-7. Equal 
number of cells was plated in 6-well plates. After growing for 
24 hours, the supernatant was collected and assayed for IL-8 
ELISA. Data are the mean ± SD of a single experiment 
assayed in triplicate and is representative of 3 separate 
experiments. **P < .001 for A2058 vs A2058T2-1. (B) IL-8 
mRNA expressionin the A2058, A2058T2-1, and A2058T2R-
7 cells. Total RNA was extracted using TRIzol reagent and 
the RNA integrity was verified by electrophoresis gel. All IL-8 
expression levels were normalized to the GAPDH levels of 
the same sample. Percent expression was calculated as the 
ratio of the normalized value of each sample to that of the 
corresponding untreated control cells. All real-time PCR 
reactions were performed in triplicate. **P < .001 for A2058 
vs A2058T2-1.
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total p-65 expression in the three cell lines: A2058 T2-1
with overexpression of TIMP-2 had less total p65 com-
pared to the parental cell line A2058. Interestingly, p-p65
increased in TIMP2 over-expressed A2058 T2-1 cells. The
relative ratio of phosphor-p65/total p65 is the highest in
the A2058 T2-1 cells compared with those in the parental
cell line A2058 and A2058 T2R-7 cells (Fig. 3B). It sug-
gests that the TIMP-2 expression is able to elevate p65
phosphorylation, thus increasing the NF-κB activity (total
IκBα↓ = p-IκBα↑ = p-p65↑ = activity of NF-κB↑). This data
is consistent with the increased IL-8 secretion and p-IκBα
expression.
Transcriptional activity of NF-κB is increased by TIMP-2
We further assessed the transcriptional activity of NF-κB
by luciferase reporter assay. NF-κB activity reporter was
transfected in the parental A2058, A2058T2-1, and A2058
T2R-7 cells. Without any stimulation, the level of NF-κB
was significantly higher in the TIMP-2 over-expressed cells
compared to that in the parental A2058 (Fig. 4). There was
no significantly difference in the transcriptional activity of
NF-κB between the parental A2058 and the A2058 T2R-7
cells (with underexpression of TIMP-2). It suggests that
endogenous TIMP-2 expression directly up-regulates the
transcriptional activity of NF-κB.
TIMP-2 overexpression inhibits TNF-induced apoptosis
Apoptosis is one of the biological effects regulated by the
NF-κB pathway. We then determined whether the TIMP-2
expression influences cell apoptosis. As showed here,
without any stimulation, the parental A2058 had about
7.07% later apoptosis/necrosis cells (Fig. 5A up-right
panel), whereas TIMP-2 underexpressed A2085T2R-7 cells
Immunoblot of whole cell IκBα and phospho-IκBα in cell  lines A2058, A2058T2-1, and A2058T2R-7 Figure 2
Immunoblot of whole cell IκBα and phospho-IκBα in 
cell lines A2058, A2058T2-1, and A2058T2R-7. (A) 
Western blot of TIMP-2, IκBα, and phospho-IκBα. (B) Densi-
tometry of IκBα and phospho-IκBα in cell lines A2058, 
A2058T2-1, and A2058T2R-7. Relative band intensity was 
determined using NIH Image 1.63 software. Data are 
reported as mean ± SD of 3 independent experiments.
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Immunoblot of whole cell NF-κBp65 and phospho- 
p65 in cell lines A2058, A2058T2-1, and A2058T2R-7. 
(A) Western blot of p65 and phospho-p65; (B) Densitometry 
of p65 and phospho-p65. Relative band intensity was deter-
mined using NIH Image 1.63 software. Data are reported as 
mean ± SD of 3 independent experiments.
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had about 8.89% apoptotic/necrotic cells, and TIMP-2
overexpression cells had 11% apoptotic/necrotic cells,
(Fig. 5C). TNF treatment induced 17.8% (Fig. 5D) apop-
tosis in the parental A2058 and 14% in A2085 T2R-7 (Fig.
5E). In contrast, there were still 11% apoptotic/necrotic
cells in TNF treated A2058T2-1 cells with TIMP-2 overex-
pression (Fig. 5F). The low-right panel in Fig. 5A repre-
sents the early apoptosis cells. After TNF treatment, the
parental A2058 had about 3.36% early apoptosis/necrosis
cells (Fig. 5A low-right panel), whereas TIMP-2 overex-
pressed A2085T2-1 cells had about 1.85% early apoptotic
cells. These data indicate that TIMP-2 over-expression is
able to protect cells from apoptosis and necrosis.
Discussion
In this study, we have used stable melanoma cell lines,
parental A2058, A2058T2-1 overexpressing TIMP-2, and
A2058T2R-7 underexpressing TIMP-2, to determine the
TIMP-2 regulation of the NF-κB activity. Our data clearly
indicate the effects of TIMP-2 on the NF-κB pathway
including the decreased basal level of IκBα, increased
phosphorylation of IκBα and NF-κB, increased transcrip-
tional NF-κB activity, and elevated IL-8 levels in the TIMP-
2-overexpressed A2028T2-1 cells. As a biological effect
regulated by the NF-κB pathway, TIMP-2 over-expression
is able to protect cells from apoptosis.
Our results demonstrate that TIMP-2 expression can
directly modulate the NF-κB pathway in melanoma cells.
Studies in lung cancer cells demonstrated that NF-κB
activity was increased by exposure to TIMP-2 as well [14].
The NF-κB transcription factor is known to act as a tumor
promoter [6,15]. It is intriguing that TIMP-2 up-regulates
NF-κB activity, whereas TIMP-2-overexpression can pre-
vent tumor invasion [16]. Other data suggest a dual func-
tion of NF-κB during tumor progression [17]. In the early
stages, NF-κB inhibits tumor growth; as further mutations
lead to a loss of tumor suppressor expression, the onco-
genic functions of NF-κB become unleashed, allowing it
to actively contribute to tumorigenesis [17]. Our data
indicate that elevated endogenous TIMP-2 can up-regulate
the NF-κB activity, which may inhibit tumor growth in the
early stage. In addition, over-expression of TIMP-2 in the
cells protects cells from apoptosis induced by proinflam-
matory cytokine TNF. After TNF stimulation, we also
measured the NF-κB transcriptional activity by the
reporter luciferase assay. We found the NF-κB transcrip-
tional activity in the TIMP-2 overexpressed cells is higher
than that in the parental A2058 with TNF treatment (data
not shown). However, the IL-8 secretion are equally high
in there cell lines after TNF stimulation. We did not find
any significant difference among these three cell line (see
additional file 1). Since the NF-κB pathway regulates
expression of a variety of cytokines and chemokines in
addition to IL-8, changes in endogenous TIMP-2 expres-
sion may result in a change in the other proinflammatory
cytokines. It will be intriguing to further determine the
effects of TIMP-2 in cells under stimulation of chronic
inflammation.
Previous studies demonstrate that alternation of the
TIMP-2-prodcution is correlated with changes in the mor-
phology, cell spread, and adhesion of the infectant A2058
cell lines. Over-expression of TIMP-2 blocks cell surface
proteolysis required for release of cells from the matrix, as
well as degradation of the extra cellular matrix, both of
which would compromise the process of cellular inva-
sion. Therefore, not surprisingly, in an in vivo angiogenesis
assay, TIMP-2-transfected cells had reduced levels of
blood vessel formation. Conditioned media from TIMP-2
transfectants diminished induction of endothelial cell
migration and invasion. TIMP-2 over-expression limited
tumor growth in vivo [16].
TIMP-2 was shown to stimulate proliferation in human
cells, including osteosarcoma cells, fibroblasts, and A549
lung adenocarcinoma cells [18-20]. Our data suggest that
TIMP-2 over-expression is able to protect cells from apop-
tosis in human melanoma A2058 cells. It is consistent
with the previous studies that TIMP-2 overexpression pro-
tects B16F10 melanoma cells from apoptosis [16]. Over-
all, these data indicate that TIPM-2 modulates other
Transcriptional activity of NF-κB in cell lines A2058,  A2058T2-1, and A2058T2R-7 Figure 4
Transcriptional activity of NF-κB in cell lines A2058, 
A2058T2-1, and A2058T2R-7. NF-κB transcription was 
measured by luciferase activity. Data are reported as mean ± 
SD of a single experiment assayed in triplicate and is repre-
sentative of 3 separate experiments. ** p < 0.001 for A2058 
group vs A2058T2-1 or A2058T2R-7 vs A2058T2-1.
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relevant aspects of the melanomatatic phenotypes includ-
ing cell proliferation and cell survival.
Previous studies showed different TIMP-2 concentration
in the condition media from these three cell lines: A2058
1.4 ng/10,000 cells/24 hours, A2058T2-1 6.8 ng/10,000
cells/24 hours, and A2058 T2R-7 0.7 ng/10,000 cells/24
hours. Alteration of TIMP-2 concentration secreted in the
media may contribute to the status of the NF-κB pathway
and IL-8 secretion in the cell media. The major focus of
current manuscript is on the cells without any stimula-
tion. In future studies, we will investigate whether
increased exogenous TIMP-2 level leads to the activation
of the NF-κB activity in melanoma cells. Since the TIMP-2
under-expressed cell line is not able to completely block
the protein expression of TIMP-2, a TIMP-2 knock-out cell
line need be established for the investigation of TIMP-2
regulation of the NF-κB activity in vitro and in vivo.
An inflammatory tumor microenvironment fosters tumor
growth, angiogenesis, and metastatic progression. Target-
ing NF-κB has potential therapeutic effects in clinical tri-
als. An important step in this direction is to delineate the
important intracellular pathways and upstream kinases
Apoptosis in A2058, A2058T2-1, and A2058T2R-7 with or without TNF-α treatment Figure 5
Apoptosis in A2058, A2058T2-1, and A2058T2R-7 with or without TNF-α treatment. After 6 h of treatment with 
TNF, 1 × 106 adherent cells were trypsinized and incubated with FITC-conjugated annexin V and propidium iodide (PI) for 15 
min in the dark. Cells were analyzed by flow cytometry. The percentages of cells in each groups within the gated areas are indi-
cated. In the gate areas, the up-right panel is for the population of later apoptotic cells and the low-right panel is for the early 
apoptosis cells. Dot plots of early apoptotic cells have increased Annexin VFITC fluorescence only, whereas necrotic and late 
apoptotic cells have increased annexin V and PI fluorescence. Axes are labelled with arbitrary fluorescence units. Data are from 
a representative of three independent experiments that gave similar results.
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involved in the up-regulation of NF-κB in melanoma
cells. Future study will identify an inflammatory link
through TIMPs and NF-κB pathway in melanoma. Under-
standing the role of TIMP and NF-κB interaction will
allow us to elucidate how inflammation modulates tum-
origenesis.
Conclusion
In summary, our results show that TIMP-2 over-expres-
sion is sufficient to increase the NF-κB activity and protect
cells from apoptosis. To our knowledge, this is the first
report on the TIMP-2 upregulation of NF-κB activity in
melanoma cells. Our data emphasize the critical role of
TIMP-2 in modulating cell survival and invasion through
the NF-κB activity.
Methods
Cell culture
Human melanoma A2058, A2058T2-1, and A2058T2R-7
cells were maintained in DMEM supplemented with 10%
FBS and penicillin-streptomycin as previously described
[9]. Equal number of cells was plated in 6-well plates.
After growing for 24 hours, cells were harvested for assays.
Immunoblotting
Cells were plated in 6-well plates. After growing for 24
hours and reaching about 70%–80% confluence, cultured
cells were rinsed twice in ice-cold HBSS, lysed in protein
loading buffer (50 mM Tris, pH 6.8, 100 mM dithiothrei-
tol, 2% SDS, 0.1% bromphenol blue, 10% glycerol), and
sonicated. Equal amount of proteins or equal volumes of
total cultured cell lysates were separated by SDS-polyacry-
lamide gel electrophoresis, transferred to nitrocellulose,
and immunoblotted with primary antibodies (1: 500 to
1000 dilution): anti-phospho-IκBα (Ser32/36) antibody
(Cell Signaling Technology, Danvers, MA, USA), anti-
phospho-p65 on serine 536 (Cell Signaling Technology),
anti-IκBα, anti-p65 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), or β-actin (Sigma-Aldrich, St. Louis, MO,
USA) antibodies and visualized by ECL as previously
described [21,22].
IL-8 secretion
Equal number of cells was plated in 6-well plates. After
growing for 24 hours, the supernatant was collected and
assayed for IL-8 using the R&D Systems human IL-8 ELISA
kit (R&D, Inc., Minneapolis, MN, USA) according to the
manufacturer's instructions as previously described [21-
23].
Quantitative real-time PCR analysis
Total RNA was extracted from epithelial cell monolayers
using TRIzol reagent (Invitrogen, Carlsbad, CA). The RNA
integrity was verified by electrophoresis gel. RNA reverse
transcription was done using the iScript cDNA synthesis
kit (Bio-Rad, Hercules, CA) according to the manufac-
turer's directions. The RT cDNA reaction products were
subjected to quantitative real-time PCR using the MyiQ
single-color real-time PCR detection system (Bio-Rad)
and iQ SYBR green supermix (Bio-Rad) according to the
manufacturer's directions. IL-8 cDNA was amplified by
using primers to the human IL-8 gene that are comple-
mentary to regions in exon 1 (5'-TGCATAAAGACAT-
ACTCCAAACCT) and overlapping the splice site between
exons 3 and 4 (5'-AATTCTCAGCCCTCTTCAAAAA). All
expression levels were normalized to the GAPDH levels of
the same sample, using forward (5-CTTCACCACCAT-
GGAGAAGGC) and reverse (5'-GGCATGGACTGTGGT-
CATGAG) primers for GAPDH. Percent expression was
calculated as the ratio of the normalized value of each
sample to that of the corresponding untreated control
cells. All real-time PCR reactions were performed in tripli-
cate. All PCR primers were designed using Lasergene soft-
ware (DNAStar, Madison, WI).
Cell transfection
Cells were grown in 24-well plates in triplicates. At ~70–
80% confluence, the cells were cotransfected with NF-κB
reporter plasmid pNF-κB-Luc (Stratagene, La Jolla, CA,
USA) and control plasmid pRL-TK (Promega, Madison,
WI, USA) using LipofectAMINE (Invitrogen, Carlsbad,
CA, USA). After 24 h, the cells were lysed, and luciferase
activity was determined using the Dual Luciferase
Reporter Assay System (Promega). Firefly luciferase activ-
ity was normalized with Renilla luciferase activity, and the
activity was expressed as relative units as previously
described [21,22].
Apoptosis assays
After 6 h of treatment with TNF, 1 × 106 adherent cells
were trypsinized and incubated with FITC-conjugated
annexin V (binds to phosphatidyl serine on the cytoplas-
mic surface of the cell membrane) and propidium iodide
(PI) for 15 min in the dark according to the manufac-
turer's protocol (Annexin VFITC Apoptosis Detection kit;
Oncogene Research Products, San Diego, CA, USA). Cells
were analyzed by flow cytometry.
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